Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki67 expression identifies a better prognosis subgroup.

Christophe Le Clorennec

Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki67 expression identifies a better prognosis subgroup.

Christophe Le Clorennec

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	200-206
Number of pages	7
Journal	HAEMATOLOGICA
Volume	90(2)
Issue number	2
Publication status	Published - Feb 2005

ASJC Scopus subject areas

Hematology

Cite this

@article{0811b614903248599d8f93aab5011400,

title = "Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki67 expression identifies a better prognosis subgroup.",

author = "{Le Clorennec}, Christophe",

year = "2005",

month = feb,

language = "English",

volume = "90(2)",

pages = "200--206",

journal = "HAEMATOLOGICA",

issn = "0390-6078",

publisher = "FERRATA STORTI FOUNDATION",

number = "2",

}

TY - JOUR

T1 - Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki67 expression identifies a better prognosis subgroup.

AU - Le Clorennec, Christophe

PY - 2005/2

Y1 - 2005/2

UR - http://www.scopus.com/inward/record.url?scp=20044392114&partnerID=8YFLogxK

M3 - Article

C2 - 15710572

SN - 0390-6078

VL - 90(2)

SP - 200

EP - 206

JO - HAEMATOLOGICA

JF - HAEMATOLOGICA

IS - 2

ER -

Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki67 expression identifies a better prognosis subgroup.

ASJC Scopus subject areas

Other files and links

Cite this